151-165 of 937
Early Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
Heart MattersEarly Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Broadcast ReplayNovel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Riccardo Maria Inciardi, MD, PhD
Cristina Gavina, MD, PhD
Giuseppe Galati, MD
Rivaroxaban as effective as warfarin for left ventricular thrombus post-MI
ACC Action CenterRivaroxaban as effective as warfarin for left ventricular thrombus post-MI
Anna Bortnick, MD, PhD
Anna Bortnick, MD, PhD
Mobile integrated health program in patients with HF
ACC Action CenterMobile integrated health program in patients with HF
Ruth Masterson Creber, PhD
Phase 3 study with oral semaglutide meets primary endpoint in high-risk T2D
ACC Action CenterPhase 3 study with oral semaglutide meets primary endpoint in high-risk T2D
Darren K. McGuire, MD
- advertisement
AI model may accelerate risk stratification of coronary revascularization in ED
ACC Action CenterAI model may accelerate risk stratification of coronary revascularization in ED
Wayne Batchelor, MD
Dapagliflozin reduces worsening HF in elderly TAVI patients
ACC Action CenterDapagliflozin reduces worsening HF in elderly TAVI patients
Wayne Batchelor, MD
Lorundrostat lowers BP in uncontrolled and treatment-resistant hypertension
ACC Action CenterLorundrostat lowers BP in uncontrolled and treatment-resistant hypertension
Gina Lundberg, MD
Gina Lundberg, MD
Fluid restriction may not be needed in chronic HF
ACC Action CenterFluid restriction may not be needed in chronic HF
Roland Kimmenade, MD, PhD
Secondary prevention strategy led by nurses reduces MACE risk after an ACS
ACC Action CenterSecondary prevention strategy led by nurses reduces MACE risk after an ACS
Giulia Magnani, MD, PhD
- advertisement
Secondary prevention post-ACS: a nurse-led intervention strategy
ACC Action CenterSecondary prevention post-ACS: a nurse-led intervention strategy
Laura Davidson, MD
Intensive medical therapy does not reduce MACE risk in women with INOCA
ACC Action CenterIntensive medical therapy does not reduce MACE risk in women with INOCA
Eileen Handberg, PhD
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
CardiologyAnalysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Akshay S. Desai, MD
